Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

Glaxosmithkline (GSK) Share News

TOP NEWS: GSK signs licence deal for Spero's tebipenem HBr antibiotic

22nd Sep 2022 08:43

(Alliance News) - GSK PLC on Thursday said it has signed an exclusive licence agreement with Massachusetts-based biotechnology firm Spero Therapeutics for the latter's tebipenem pivoxil hydrobromide, or tebipenem HBr. Read More

TOP NEWS SUMMARY: Haleon makes positive start separate from GSK

20th Sep 2022 10:59

(Alliance News) - The following is a summary of top news stories Tuesday. Read More

TOP NEWS: Haleon makes good earnings debut with interim revenue rise

20th Sep 2022 09:08

(Alliance News) - Haleon PLC on Tuesday reported a strong performance in the first half of 2022 in its first earnings report since being split from GSK PLC in July and separately listed, noting double-digit revenue growth and profit rise. Read More

LONDON BRIEFING: Haleon reports double-digit revenue growth

20th Sep 2022 07:51

(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More

TOP NEWS: Two AstraZeneca drugs get recommendations for EU approval

16th Sep 2022 08:16

(Alliance News) - AstraZeneca PLC on Friday said it received two recommendations for drug approvals in the EU, while a drug for blood disorder paroxysmal nocturnal haemoglobinuria met its primary endpoint in a phase three trial. Read More

LONDON BROKER RATINGS: Credit Suisse cuts AstraZeneca and raises GSK

15th Sep 2022 09:30

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Friday: Read More

LONDON BROKER RATINGS: Stifel downgrades IAG, easyJet and Ryanair

14th Sep 2022 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday: Read More

GSK says niraparib shows sustained benefit in ovarian cancer patients

9th Sep 2022 14:34

(Alliance News) - GSK PLC on Friday said niraparib, sold under the brand name Zejula, has shown long-term survival benefit in an ovarian cancer study. Read More

LONDON BROKER RATINGS: Morgan Stanley cuts ITV to 'underweight'

8th Sep 2022 09:22

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning: Read More

LONDON BROKER RATINGS: UBS raises Admiral; Morgan Stanley cuts Astra

7th Sep 2022 09:47

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday afternoon: Read More

GSK malaria vaccine gets WHO boost; FDA reviews kidney disease drug

6th Sep 2022 14:07

(Alliance News) - GSK PLC on Tuesday said the World Health Organisation made it easier for its malaria vaccine Mosquirix to be rolled out while the US Food & Drug Administration is reviewing the firm's kidney disease drug, daprodustat. Read More

GSK to present data on ovarian and endometrial cancer drugs in Paris

1st Sep 2022 10:13

(Alliance News) - Biopharma firm GSK PLC on Thursday said it will present new data on its ovarian cancer and endometrial cancer drugs from September 9 to 13 at the European Society for Medical Oncology Congress 2022 in Paris. Read More

LONDON MARKET CLOSE: FTSE 100 keeps head above water as pound sinks

19th Aug 2022 17:07

(Alliance News) - The FTSE 100 managed to outperform European counterparts on Friday due to weakness in the pound as consumer confidence in the UK fell to a record low, while attention turns to next week's Jackson Hole Symposium. Read More

LONDON MARKET MIDDAY: Weaker pound unable to keep FTSE in green

19th Aug 2022 12:06

(Alliance News) - London's FTSE 100 outperformed peers but was unable to stave off selling pressure in a tough session for European stocks on Friday, despite sitting just above positive territory for much of the late-morning's trade. Read More

LONDON BROKER RATINGS: Jefferies likes AO, Berenberg lifts Devolver

18th Aug 2022 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday: Read More

TOP NEWS: US FDA accepts GSK's new drug application for momelotinib

17th Aug 2022 08:17

(Alliance News) - GSK PLC on Wednesday said the US Food & Drug Administration has accepted the new drug application for its momelotinib, which could potentially treat a rare blood cancer myelofibrosis. Read More

TOP NEWS: GSK scores victory as first Zantac dismissed from court

16th Aug 2022 20:06

(Alliance News) - GSK PLC said on Tuesday the first scheduled trial in its Zantac case has been voluntarily dismissed. Read More

GSK completes acquisition of biopharmaceutical firm Affinivax

16th Aug 2022 08:29

(Alliance News) - GSK PLC on Tuesday said it has completed the acquisition of Massachusetts-based clinical-stage biopharmaceutical company Affinivax Inc. Read More

LONDON MARKET CLOSE: Slowing US CPI lifts FTSE to fourth weekly gain

12th Aug 2022 17:01

(Alliance News) - The FTSE 100 ended a largely positive week on solid footing, with markets on Friday continuing to digest some encouraging inflation figures in the US. Read More

LONDON MARKET MIDDAY: Inflation "dominant" theme amid signs of cooling

12th Aug 2022 12:15

(Alliance News) - Stock prices in London were slightly higher at midday on Friday with markets trading on optimism about US inflation, which is showing signs of easing. Read More

FTSE 100 Latest

Value9,483.58

Change4.44